Literature DB >> 23579640

Identification of miR-221 and -222 as important regulators in genotype IV swine hepatitis E virus ORF3-expressing HEK 293 cells.

Ying Cheng1, Li Du, Qiaoyun Shi, Hanwei Jiao, Xiaoru Zhang, Yongchang Hao, Hui Rong, Jianing Zhang, Xiaoxiao Jia, Shiyu Guo, Wenhua Kuang, Hui Zhang, Chuangfu Chen, Fengyang Wang.   

Abstract

Hepatitis E virus (HEV) has emerged as an important cause of epidemic and sporadic acute viral hepatitis worldwide, which is a major public health challenge. A better understanding of the interaction between the virus and the host cell would be very helpful for its therapy. Swine HEV (SHEV) open reading frame 3 (ORF3) is a regulatory protein that alters the activity of selected transcription factors and cytoplasmic signaling pathways. MicroRNAs (miRNAs) are potent post-transcriptional regulators of protein-coding genes and represent an interesting lead to study SHEV infection and to identify new therapeutic targets. To explore how SHEV ORF3 affects miRNAs in host cells, we used miRNA array analysis to compare the expression patterns of miRNAs in stable cell lines that expressed or did not express SHEV ORF3. We found a significant down-regulation of miR-221 and -222 in ORF3 expressing human embryonic kidney 293 cell line. Among the 116 candidate targets genes of miR-221 and -222 that we detected in silico, we demonstrated that the expression of the cyclin-dependent kinase inhibitor 1B, also named p27(kip1), was directly regulated by these miRNAs. We hypothesize that SHEV ORF3-induced miR-221/222 downregulation enhances p27(kip1) expression in HEK293 cells. This provides new avenues for future exploration of the precise roles of miRNAs in SHEV infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23579640     DOI: 10.1007/s11262-013-0912-4

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  28 in total

Review 1.  Regulation of the cell cycle at the G1-S transition by proteolysis of cyclin E and p27Kip1.

Authors:  K I Nakayama; S Hatakeyama; K Nakayama
Journal:  Biochem Biophys Res Commun       Date:  2001-04-13       Impact factor: 3.575

2.  A novel virus in swine is closely related to the human hepatitis E virus.

Authors:  X J Meng; R H Purcell; P G Halbur; J R Lehman; D M Webb; T S Tsareva; J S Haynes; B J Thacker; S U Emerson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

Review 3.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

4.  The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase.

Authors:  Anindita Kar-Roy; Hasan Korkaya; Ruchi Oberoi; Sunil Kumar Lal; Shahid Jameel
Journal:  J Biol Chem       Date:  2004-04-19       Impact factor: 5.157

5.  Genetic characterization and sequence heterogeneity of a canadian isolate of Swine hepatitis E virus.

Authors:  Yanlong Pei; Dongwan Yoo
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

6.  RNA interference induces effective inhibition of mRNA accumulation and protein expression of SHEV ORF3 gene in vitro.

Authors:  Tao Liu; Ming Lei; Hanwei Jiao; Li Du; Ying Cheng; Donglin Zhang; Yongchang Hao; Churiga Man; Fengyang Wang
Journal:  Curr Microbiol       Date:  2011-01-12       Impact factor: 2.188

7.  MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle.

Authors:  Rosa Visone; Lucia Russo; Pierlorenzo Pallante; Ivana De Martino; Angelo Ferraro; Vincenza Leone; Eleonora Borbone; Fabio Petrocca; Hansjuerg Alder; Carlo Maria Croce; Alfredo Fusco
Journal:  Endocr Relat Cancer       Date:  2007-09       Impact factor: 5.678

8.  Hepatitis E virus genotype diversity in eastern China.

Authors:  Wen Zhang; Yilin He; Hua Wang; Quan Shen; Li Cui; Xiaochun Wang; Shihe Shao; Xiuguo Hua
Journal:  Emerg Infect Dis       Date:  2010-10       Impact factor: 6.883

9.  Features of mammalian microRNA promoters emerge from polymerase II chromatin immunoprecipitation data.

Authors:  David L Corcoran; Kusum V Pandit; Ben Gordon; Arindam Bhattacharjee; Naftali Kaminski; Panayiotis V Benos
Journal:  PLoS One       Date:  2009-04-23       Impact factor: 3.240

10.  miR-200 enhances mouse breast cancer cell colonization to form distant metastases.

Authors:  Derek M Dykxhoorn; Yichao Wu; Huangming Xie; Fengyan Yu; Ashish Lal; Fabio Petrocca; Denis Martinvalet; Erwei Song; Bing Lim; Judy Lieberman
Journal:  PLoS One       Date:  2009-09-29       Impact factor: 3.240

View more
  4 in total

1.  Expression Profile Analysis of miR-221 and miR-222 in Different Tissues and Head Kidney Cells of Cynoglossus semilaevis, Following Pathogen Infection.

Authors:  Hui Yan; Yadong Chen; Shun Zhou; Chao Li; Guangye Gong; Xuejie Chen; Tianzi Wang; Songlin Chen; Zhenxia Sha
Journal:  Mar Biotechnol (NY)       Date:  2015-09-29       Impact factor: 3.619

2.  Transcriptome Analysis of HepG2 Cells Expressing ORF3 from Swine Hepatitis E Virus to Determine the Effects of ORF3 on Host Cells.

Authors:  Kailian Xu; Shiyu Guo; Tianjing Zhao; Huapei Zhu; Hanwei Jiao; Qiaoyun Shi; Feng Pang; Yaying Li; Guohua Li; Dongmei Peng; Xin Nie; Ying Cheng; Kebang Wu; Li Du; Ke Cui; Wenguang Zhang; Fengyang Wang
Journal:  Biomed Res Int       Date:  2016-08-28       Impact factor: 3.411

3.  Specific circulating microRNAs during hepatitis E infection can serve as indicator for chronic hepatitis E.

Authors:  Dominik Harms; Mira Choi; Kristina Allers; Bo Wang; Heiko Pietsch; C-Patrick Papp; Lina Hanisch; Jens Kurreck; Jörg Hofmann; C-Thomas Bock
Journal:  Sci Rep       Date:  2020-03-24       Impact factor: 4.379

4.  Identifying Circular RNAs in HepG2 Expressing Genotype IV Swine Hepatitis E Virus ORF3 Via Whole Genome Sequencing.

Authors:  Hanwei Jiao; Yu Zhao; Zhixiong Zhou; Wenjie Li; Bowen Li; Guojing Gu; Yichen Luo; Xuehong Shuai; Cailiang Fan; Li Wu; Jixuan Chen; Qingzhou Huang; Fengyang Wang; Juan Liu
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.